Heightened Vigilance Needed When Patients Are Prescribed GLP-1 and GIP Agonists
Authors
- William K. Silverstein (ORCID: https://orcid.org/0000-0002-4133-7369)
- Tyrone Johnson (ORCID: https://orcid.org/0000-0003-3833-1123)
- Michael A. Incze (ORCID: https://orcid.org/0000-0002-1468-930X)
Institutions
- Sunnybrook Health Science Centre (CA)
- University of California, San Francisco (US)
- University of Toronto (CA)
- University of Utah (US)
- Health Sciences Centre (CA)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1001/jamainternmed.2024.3732
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.79